191 related articles for article (PubMed ID: 10232593)
1. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen.
Terashima I; Suzuki N; Shibutani S
Cancer Res; 1999 May; 59(9):2091-5. PubMed ID: 10232593
[TBL] [Abstract][Full Text] [Related]
2. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
[TBL] [Abstract][Full Text] [Related]
3. Miscoding potential of tamoxifen-derived DNA adducts: alpha-(N2-deoxyguanosinyl)tamoxifen.
Shibutani S; Dasaradhi L
Biochemistry; 1997 Oct; 36(42):13010-7. PubMed ID: 9335562
[TBL] [Abstract][Full Text] [Related]
4. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
[TBL] [Abstract][Full Text] [Related]
5. Mutagenic specificity of model estrogen-DNA adducts in mammalian cells.
Terashima I; Suzuki N; Itoh S; Yoshizawa I; Shibutani S
Biochemistry; 1998 Jun; 37(24):8803-7. PubMed ID: 9628742
[TBL] [Abstract][Full Text] [Related]
6. Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa.
Yasui M; Suzuki N; Laxmi YR; Shibutani S
Biochemistry; 2006 Oct; 45(39):12167-74. PubMed ID: 17002316
[TBL] [Abstract][Full Text] [Related]
7. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
[TBL] [Abstract][Full Text] [Related]
8. Accomodation of S-cis-tamoxifen-N(2)-guanine adduct within a bent and widened DNA minor groove.
Shimotakahara S; Gorin A; Kolbanovskiy A; Kettani A; Hingerty BE; Amin S; Broyde S; Geacintov N; Patel DJ
J Mol Biol; 2000 Sep; 302(2):377-93. PubMed ID: 10970740
[TBL] [Abstract][Full Text] [Related]
9. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen.
Shibutani S; Ravindernath A; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
Carcinogenesis; 2000 Aug; 21(8):1461-7. PubMed ID: 10910945
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic properties of 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene, a persistent acetylaminofluorene-derived DNA adduct in mammalian cells.
Yasui M; Dong H; Bonala RR; Suzuki N; Ohmori H; Hanaoka F; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Nov; 43(47):15005-13. PubMed ID: 15554708
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic potential of stereoisomeric bay region (+)- and (-)-cis-anti-benzo[a]pyrene diol epoxide-N2-2'-deoxyguanosine adducts in Escherichia coli and simian kidney cells.
Fernandes A; Liu T; Amin S; Geacintov NE; Grollman AP; Moriya M
Biochemistry; 1998 Jul; 37(28):10164-72. PubMed ID: 9665722
[TBL] [Abstract][Full Text] [Related]
12. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K
Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen.
Shibutani S; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
Chem Res Toxicol; 1999 Jul; 12(7):646-53. PubMed ID: 10409405
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of oligodeoxynucleotides containing a single diastereoisomer of alpha-(N2-2'-deoxyguanosinyl)-N-desmethyltamoxifen.
Laxmi YR; Suzuki N; Kim SY; Shibutani S
Bioorg Med Chem Lett; 2004 Aug; 14(15):4051-4. PubMed ID: 15225724
[TBL] [Abstract][Full Text] [Related]
15. Preparation of oligodeoxynucleotides containing a diastereoisomer of alpha-(N(2)-2'-deoxyguanosinyl)tamoxifen by phosphoramidite chemical synthesis.
Santosh Laxmi YR; Suzuki N; Dasaradhi L; Johnson F; Shibutani S
Chem Res Toxicol; 2002 Feb; 15(2):218-25. PubMed ID: 11849048
[TBL] [Abstract][Full Text] [Related]
16. Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2'-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality.
Moriya M; Spiegel S; Fernandes A; Amin S; Liu T; Geacintov N; Grollman AP
Biochemistry; 1996 Dec; 35(51):16646-51. PubMed ID: 8988000
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
18. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
19. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
[TBL] [Abstract][Full Text] [Related]
20. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
